Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(13%)
Results Posted
67%(4 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
4
27%
Ph phase_1
2
13%
Ph phase_4
4
27%
Ph phase_2
2
13%

Phase Distribution

2

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
2(16.7%)
Phase 4Post-market surveillance
4(33.3%)
N/ANon-phased studies
4(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

6 of 10 finished

Non-Completion Rate

40.0%

4 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(5)
Completed(6)
Terminated(4)

Detailed Status

Completed6
Withdrawn3
Not yet recruiting2
Recruiting2
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (16.7%)
Phase 22 (16.7%)
Phase 44 (33.3%)
N/A4 (33.3%)

Trials by Status

enrolling_by_invitation17%
not_yet_recruiting213%
recruiting213%
terminated17%
withdrawn320%
completed640%

Recent Activity

2 active trials
Showing 5 of 15
not_yet_recruiting

Human Pain Atlas for Sensory Neurons

NCT07740681
recruitingnot_applicable

Microneurography and Intraneural Microstimulation for Upper Limb Sensory Investigation in Healthy and Amputee Subjects

NCT07691957
recruitingphase_2

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

NCT02560805
enrolling_by_invitationnot_applicable

Autoimmune Basis for Postural Tachycardia Syndrome

NCT02725060
not_yet_recruiting

Auto-immune Contribution in Symptom-based Sensory and Autonomic Disorders

NCT06992531
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07740681

Human Pain Atlas for Sensory Neurons

Not Yet Recruiting
NCT07691957Not Applicable

Microneurography and Intraneural Microstimulation for Upper Limb Sensory Investigation in Healthy and Amputee Subjects

Recruiting
NCT02560805Phase 2

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

Recruiting
NCT02725060Not Applicable

Autoimmune Basis for Postural Tachycardia Syndrome

Enrolling By Invitation
NCT06992531

Auto-immune Contribution in Symptom-based Sensory and Autonomic Disorders

Not Yet Recruiting
NCT03539081Not Applicable

Spinal Cord Stimulation for Restless Legs Syndrome

Completed
NCT02102243Phase 4

Neural Mechanism of Aldosterone-induced Insulin Resistance

Withdrawn
NCT01996449Phase 2

The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension

Completed
NCT00748059Phase 1

The Pathophysiology of Orthostatic Hypotension

Completed
NCT01502787Phase 4

Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients

Completed
NCT03640221Phase 4

Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.

Withdrawn
NCT02787798Phase 4

Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure

Terminated
NCT00338546Phase 1

Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine

Withdrawn
NCT00759967Not Applicable

Conventional Hemodialysis vs. Short Daily Hemodialysis (6 Days / Week) and Mechanisms of Blood Pressure Control

Completed
NCT00439790

Sympathetic Nerve Activity and an Implantable Cardioverter Defibrillator in Heart Failure Patients

Completed

All 15 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
15